TsGRM Genetiko PAO

TsGRM Genetiko PAO Current Assets

The Current Assets of TsGRM Genetiko PAO (GECO.ME) as of Oct 28, 2026 is 122.46 M RUB. In the previous year, Current Assets was 114.75 M RUB — a change of 6.71% (higher).

Current Assets

122.46 MRUB

YoY

6.71%

Last updated:

Current Assets of TsGRM Genetiko PAO is 2024 122.46 M RUB. Current Assets of TsGRM Genetiko PAO was 2023 114.75 M RUB. It decreases by 6.71% higher compared to the previous year.

The TsGRM Genetiko PAO Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2022
118.95 M RUB
Jan 1, 2023
114.75 M RUB
Jan 1, 2024
122.46 M RUB
The TsGRM Genetiko PAO Current Assets history
YEARCurrent AssetsYoY
122.46 MRUB+6.71%
114.75 MRUB-3.53%
118.95 MRUB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TsGRM Genetiko PAO Stock analysis

What does TsGRM Genetiko PAO do? TsGRM Genetiko PAO generates revenue through medical genetic services provided to doctors and patients via its four specialized laboratories. The company offers complex genetic diagnostics for hereditary diseases and reproductive disorders through its Next-Generation Sequencing (NGS) laboratory, Non-Invasive Prenatal Testing (NIPT) laboratory, Oncogenetics laboratory, and Genotyping laboratory. These services are delivered to healthcare professionals and individuals seeking genetic analysis. The firm's laboratory and production complexes form the core of its service delivery model, focusing on diagnostic solutions for medical genetics. TsGRM Genetiko PAO's primary customers are doctors who order genetic tests for their patients and patients directly seeking genetic diagnostics. The company's services include hereditary disease diagnostics and reproductive disorder assessments, which are conducted in its dedicated laboratory facilities. The firm's business model centers on providing specialized genetic testing services through its internal laboratory infrastructure without external partnerships or additional product lines. The company operates exclusively within the medical genetic services sector, delivering diagnostic solutions through its four laboratory divisions. Revenue is derived from the execution of genetic tests across all laboratory types, with no mention of additional product lines or external collaborations. The firm's structure is defined by its internal laboratory network, which serves both medical professionals and end patients. TsGRM Genetiko PAO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TsGRM Genetiko PAO stock

Current Assets of TsGRM Genetiko PAO is 122.46 M RUB in 2024.

Current Assets of TsGRM Genetiko PAO changed from 114.75 M RUB to 122.46 M RUB, representing a 6.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets TsGRM Genetiko PAO since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's RUB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's TsGRM Genetiko PAO historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — TsGRM Genetiko PAO

All Key Metrics — TsGRM Genetiko PAO